Kanak Raina

4.2k total citations · 2 hit papers
23 papers, 3.0k citations indexed

About

Kanak Raina is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Kanak Raina has authored 23 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Hematology and 7 papers in Oncology. Recurrent topics in Kanak Raina's work include Protein Degradation and Inhibitors (19 papers), Ubiquitin and proteasome pathways (9 papers) and Multiple Myeloma Research and Treatments (8 papers). Kanak Raina is often cited by papers focused on Protein Degradation and Inhibitors (19 papers), Ubiquitin and proteasome pathways (9 papers) and Multiple Myeloma Research and Treatments (8 papers). Kanak Raina collaborates with scholars based in United States, United Kingdom and France. Kanak Raina's co-authors include Craig M. Crews, Andrew P. Crew, Yimin Qian, Kevin Coleman, Jing Wang, Hanqing Dong, James D. Winkler, Martha Altieri, Jing Lü and John Hines and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Kanak Raina

22 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4

2015 849 citations Jing Lü, Yimin Qian et al. Chemistry & Biology profile →
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer

2016 661 citations Kanak Raina, Jing Lü et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kanak Raina United States	14	2.8k	996	828	166	135	23	3.0k
Joshiawa Paulk United States	14	3.4k 1.2×	998 1.0×	845 1.0×	138 0.8×	86 0.6×	18	3.6k
Justin M. Roberts United States	12	2.4k 0.9×	669 0.7×	594 0.7×	124 0.7×	94 0.7×	17	2.6k
Taavi K. Neklesa United States	18	2.0k 0.7×	784 0.8×	380 0.5×	141 0.8×	155 1.1×	25	2.2k
Georg Winter United States	12	1.8k 0.6×	589 0.6×	300 0.4×	63 0.4×	63 0.5×	20	2.0k
Brian E. Cathers United States	17	2.2k 0.8×	619 0.6×	904 1.1×	121 0.7×	54 0.4×	31	2.6k
Ronald M. Paranal United States	11	1.8k 0.6×	480 0.5×	264 0.3×	168 1.0×	82 0.6×	17	2.2k
Antonia Lopez‐Girona United States	22	3.1k 1.1×	1.1k 1.1×	1.2k 1.5×	61 0.4×	587 4.3×	58	3.6k
Kwok-Ho Chan United Kingdom	14	2.4k 0.8×	920 0.9×	723 0.9×	122 0.7×	40 0.3×	17	2.5k
Nicholas Kwiatkowski United States	31	3.2k 1.1×	1.5k 1.5×	393 0.5×	273 1.6×	478 3.5×	48	3.9k
Mohammad Azam United States	18	694 0.2×	318 0.3×	856 1.0×	144 0.9×	59 0.4×	36	1.6k

Countries citing papers authored by Kanak Raina

Since Specialization

Citations

This map shows the geographic impact of Kanak Raina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanak Raina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanak Raina more than expected).

Fields of papers citing papers by Kanak Raina

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanak Raina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanak Raina. The network helps show where Kanak Raina may publish in the future.

Co-authorship network of co-authors of Kanak Raina

This figure shows the co-authorship network connecting the top 25 collaborators of Kanak Raina. A scholar is included among the top collaborators of Kanak Raina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanak Raina. Kanak Raina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Raina, Kanak, Kyle J. Eastman, Xinheng Yu, et al.. (2023). An oral androgen receptor RIPTAC for prostate cancer.. Journal of Clinical Oncology. 41(6_suppl). 184–184. 7 indexed citations

Mill, Christopher P., Warren Fiskus, Courtney D. DiNardo, et al.. (2019). RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1. Blood. 134(1). 59–73. 77 indexed citations

Neklesa, Taavi K., Lawrence B. Snyder, Ryan R. Willard, et al.. (2018). An oral androgen receptor PROTAC degrader for prostate cancer.. Journal of Clinical Oncology. 36(6_suppl). 381–381. 14 indexed citations

Neklesa, Taavi K., Lawrence B. Snyder, Ryan R. Willard, et al.. (2018). Abstract 5236: ARV-110: An androgen receptor PROTAC degrader for prostate cancer. Cancer Research. 78(13_Supplement). 5236–5236. 50 indexed citations

Mill, Christopher P., Warren Fiskus, Courtney D. DiNardo, et al.. (2017). Targeted Therapy for AML Expressing RUNX1 Mutation. Blood. 130. 2472–2472. 1 indexed citations

Raina, Kanak & Craig M. Crews. (2017). Targeted protein knockdown using small molecule degraders. Current Opinion in Chemical Biology. 39. 46–53. 98 indexed citations

Sun, Baohua, Warren Fiskus, Yimin Qian, et al.. (2017). BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells. Leukemia. 32(2). 343–352. 136 indexed citations

Piya, Sujan, Hong Mu, Seemana Bhattacharya, et al.. (2017). BRD4 Proteolysis Targeting Chimera (PROTAC) ARV-825 Targets Both NOTCH1-MYC Regulatory Circuit and Leukemia-Microenvironment in T-ALL. Blood. 130(Suppl_1). 716–716. 1 indexed citations

Crew, Andrew P., Kanak Raina, Hanqing Dong, et al.. (2017). Identification and Characterization of Von Hippel-Lindau-Recruiting Proteolysis Targeting Chimeras (PROTACs) of TANK-Binding Kinase 1. Journal of Medicinal Chemistry. 61(2). 583–598. 195 indexed citations

10.

Neklesa, Taavi K., Lawrence B. Snyder, Mark Bookbinder, et al.. (2017). An oral androgen receptor PROTAC degrader for prostate cancer.. Journal of Clinical Oncology. 35(6_suppl). 273–273. 23 indexed citations

11.

Neklesa, Taavi K., Lawrence B. Snyder, Mark Bookbinder, et al.. (2017). Abstract 5637: An oral Androgen Receptor PROTAC degrader for prostate cancer. Cancer Research. 77(13_Supplement). 5637–5637. 2 indexed citations

12.

Winkler, Julia, Kanak Raina, Martha Altieri, et al.. (2016). PROTAC BET degraders are more broadly effective than BET inhibitors. European Journal of Cancer. 69. S10–S10. 3 indexed citations

13.

Raina, Kanak, Jing Lü, Yimin Qian, et al.. (2016). PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer. Proceedings of the National Academy of Sciences. 113(26). 7124–7129. 661 indexed citations breakdown →

14.

Saenz, Dyana T., Warren Fiskus, Kanak Raina, et al.. (2016). Superior Lethal Activity of Novel BET Protein Proteolysis Targeting Chimera (BETP-PROTACs) Versus Betp Bromodomain Inhibitor (BETi) Against Post-Myeloproliferative Neoplasm (MPN) Secondary (s) AML Cells. Blood. 128(22). 747–747. 1 indexed citations

15.

Lü, Jing, Yimin Qian, Martha Altieri, et al.. (2015). Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4. Chemistry & Biology. 22(6). 755–763. 849 indexed citations breakdown →

16.

Lü, Jing, Yimin Qian, Kanak Raina, et al.. (2015). BRD4 Degradation By Protacs Represents a More Effective Therapeutic Strategy Than BRD4 Inhibitors in DLBCL. Blood. 126(23). 2050–2050. 3 indexed citations

17.

Raina, Kanak, et al.. (2014). Targeted protein destabilization reveals an estrogen-mediated ER stress response. Nature Chemical Biology. 10(11). 957–962. 70 indexed citations

18.

Tae, Hyun Seop, Thomas B. Sundberg, Taavi K. Neklesa, et al.. (2012). Identification of Hydrophobic Tags for the Degradation of Stabilized Proteins. ChemBioChem. 13(4). 538–541. 83 indexed citations

19.

Neklesa, Taavi K., Hyun Seop Tae, Michael J. Stulberg, et al.. (2011). Small-molecule hydrophobic tagging–induced degradation of HaloTag fusion proteins. Nature Chemical Biology. 7(8). 538–543. 322 indexed citations

20.

Raina, Kanak & Craig M. Crews. (2010). Chemical Inducers of Targeted Protein Degradation. Journal of Biological Chemistry. 285(15). 11057–11060. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact